Understanding genetic analysis for breast cancer and its implications for plastic surgery
Hooman Soltanian1, Haruko Okada
1Department of Plastic Surgery, Case Medical Center, 29017 Cedar Rd, Cleveland, OH 44124, USA. Hooman.Soltanian@uhhospitals.org
Aesthetic Surgery Journal
|December 17, 2008
Summary
Plastic surgeons should assess cosmetic breast procedure patients for breast cancer risk. Identifying high-risk individuals for genetic testing and counseling is crucial for informed decision-making.
Area of Science:
- Oncology
- Plastic Surgery
- Genetics
Background:
- Cosmetic breast procedures are common.
- A subset of patients may have increased breast cancer risk.
- Early identification of high-risk patients is essential.
Purpose of the Study:
- To review current information and clinical tools for identifying high-risk patients.
- To guide plastic surgeons in assessing breast cancer risk in patients seeking cosmetic breast procedures.
- To emphasize the importance of genetic testing and counseling.
Main Methods:
- Literature review of current information and clinical tools.
- Discussion of BRCA 1 and 2 mutations' role in breast cancer.
- Emphasis on multidisciplinary approach and patient counseling.
Main Results:
- BRCA 1 and 2 mutations contribute to 5-10% of breast cancer cases.
- High-risk patients require referral to medical oncologists and geneticists.
- Plastic surgeons play a key role in multidisciplinary treatment planning.
Conclusions:
- Plastic surgeons must assess breast cancer risk in patients undergoing cosmetic breast procedures.
- Genetic counseling and testing are vital for high-risk individuals.
- Involvement of plastic surgeons ensures comprehensive patient care, including surgical planning and aesthetic expectations.

